{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:19:46Z","timestamp":1788355186466,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yantai Science and Technology Innovation Development Plan","award":["2024YD053"],"award-info":[{"award-number":["2024YD053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening conditions with substantial mortality and limited targeted therapies. The pregnane X receptor (PXR) has emerged as a promising therapeutic target for inflammatory diseases, though its role in ALI remains underexplored. This study characterizes phillygenin (PHI), a bioactive lignan isolated from Forsythia suspensa, as a PXR agonist, elucidating its protective mechanism in lipopolysaccharide (LPS)-induced ALI. PHI binding to PXR was characterized by ligand fishing using hollow fibers and luciferase reporter assays, revealing direct agonistic activity. In LPS-stimulated human bronchial epithelial cells, PHI-activated PXR competed with NF-\u03baB p65 for RXR\u03b1, suppressing NF-\u03baB p65 nuclear translocation and downstream inflammatory cascades. Concurrently, PHI upregulated antioxidant enzymes (GPX-2\/GPX-7) and anti-apoptotic proteins (Bcl-2\/Bcl-xL), while downregulating pro-inflammatory mediators (TNF-\u03b1, IL-6), in a PXR-dependent manner. PXR knockdown abolished these protective effects, confirming target specificity. In vivo, PHI dose-dependently attenuated lung histopathological injury, reduced inflammatory cytokine levels in bronchoalveolar lavage fluid, and mitigated alveolar epithelial apoptosis in LPS-challenged mice. These findings support PHI as a direct PXR agonist and the PHI-PXR-NF-\u03baB axis as a mechanistic foundation for developing targeted interventions in acute inflammatory lung diseases.<\/jats:p>","DOI":"10.1038\/s41598-026-66771-z","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:13:30Z","timestamp":1787991210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phillygenin protects against lipopolysaccharide-induced acute lung injury by acting as a PXR agonist via NF-\u03baB inhibition"],"prefix":"10.1038","volume":"16","author":[{"given":"Cong-jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-da","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-ping","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"10358","key":"66771_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos, L. D. J. & Ware, L. B. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet 400(10358), 1145\u20131156. https:\/\/doi.org\/10.1016\/S0140-6736(22)01485-4 (2022).","journal-title":"Lancet"},{"issue":"10","key":"66771_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/CS20210879","volume":"136","author":"ME Long","year":"2022","unstructured":"Long, M. E., Mallampalli, R. K. & Horowitz, J. C. Pathogenesis of pneumonia and acute lung injury. Clin. Sci. (Lond). 136(10), 747\u2013769. https:\/\/doi.org\/10.1042\/CS20210879 (2022).","journal-title":"Clin. Sci. (Lond)"},{"issue":"1","key":"66771_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12967-025-06994-2","volume":"23","author":"H Liu","year":"2025","unstructured":"Liu, H. et al. Acute lung injury: pathogenesis and treatment. J. Transl Med. 23(1), 926. https:\/\/doi.org\/10.1186\/s12967-025-06994-2 (2025).","journal-title":"J. Transl Med."},{"issue":"8","key":"66771_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani, G. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8), 788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291 (2016).","journal-title":"JAMA"},{"issue":"1","key":"66771_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13054-020-03112-0","volume":"24","author":"X Huang","year":"2020","unstructured":"Huang, X. et al. Incidence and outcomes of acute respiratory distress syndrome in intensive care units of mainland China: a multicentre prospective longitudinal study. Crit. Care. 24(1), 515. https:\/\/doi.org\/10.1186\/s13054-020-03112-0 (2020).","journal-title":"Crit. Care"},{"issue":"1","key":"66771_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","volume":"209","author":"N Qadir","year":"2024","unstructured":"Qadir, N. et al. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline. Am. J. Respir Crit. Care Med. 209(1), 24\u201336. https:\/\/doi.org\/10.1164\/rccm.202311-2011ST (2024).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"6","key":"66771_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/17476348.2020.1743182","volume":"14","author":"MF Mart","year":"2020","unstructured":"Mart, M. F. & Ware, L. B. The long-lasting effects of the acute respiratory distress syndrome. Expert Rev. Respir Med. 14(6), 577\u2013586. https:\/\/doi.org\/10.1080\/17476348.2020.1743182 (2020).","journal-title":"Expert Rev. Respir Med."},{"issue":"3","key":"66771_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/antiox12030548","volume":"12","author":"FS Bezerra","year":"2023","unstructured":"Bezerra, F. S. et al. Oxidative stress and inflammation in acute and chronic lung injuries. Antioxid. (Basel). 12(3), 548. https:\/\/doi.org\/10.3390\/antiox12030548 (2023).","journal-title":"Antioxid. (Basel)"},{"issue":"9","key":"66771_CR9","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/biomedicines13092299","volume":"13","author":"J Wang","year":"2025","unstructured":"Wang, J. & Chao, J. Alveolar Epithelial Cell Dysfunction in Acute Respiratory Distress Syndrome: Mechanistic Insights and Targeted Interventions. Biomedicines 13(9), 2299. https:\/\/doi.org\/10.3390\/biomedicines13092299 (2025).","journal-title":"Biomedicines"},{"key":"66771_CR10","doi-asserted-by":"publisher","first-page":"116773","DOI":"10.1016\/j.biopha.2024.116773","volume":"175","author":"J Zheng","year":"2024","unstructured":"Zheng, J., Li, Y., Kong, X. & Guo, J. Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI\/ARDS. Biomed. Pharmacother. 175, 116773. https:\/\/doi.org\/10.1016\/j.biopha.2024.116773 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"4","key":"66771_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/resp.12978","volume":"22","author":"C Cilloniz","year":"2017","unstructured":"Cilloniz, C. et al. Seasonality of pathogens causing community-acquired pneumonia. Respirology 22(4), 778\u2013785. https:\/\/doi.org\/10.1111\/resp.12978 (2017).","journal-title":"Respirology"},{"issue":"20","key":"66771_CR12","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.3390\/cells11203317","volume":"11","author":"MW Millar","year":"2022","unstructured":"Millar, M. W., Fazal, F. & Rahman, A. Therapeutic Targeting of NF-\u03baB in Acute Lung Injury: A Double-Edged Sword. Cells 11(20), 3317. https:\/\/doi.org\/10.3390\/cells11203317 (2022).","journal-title":"Cells"},{"issue":"1","key":"66771_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cr.2011.1","volume":"21","author":"SC Sun","year":"2011","unstructured":"Sun, S. C. & Liu, Z. G. A special issue on NF-\u03baB signaling and function. Cell. Res. 21(1), 1\u20132. https:\/\/doi.org\/10.1038\/cr.2011.1 (2011).","journal-title":"Cell. Res."},{"issue":"1\u20132","key":"66771_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., Lenardo, M. J. & Baltimore, D. 30 Years of NF-\u03baB: A Blossoming of Relevance to Human Pathobiology. Cell 168(1\u20132), 37\u201357. https:\/\/doi.org\/10.1016\/j.cell.2016.12.012 (2017).","journal-title":"Cell"},{"issue":"4","key":"66771_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","volume":"140","author":"Y Butt","year":"2016","unstructured":"Butt, Y., Kurdowska, A. & Allen, T. C. Acute Lung Injury: A Clinical and Molecular Review. Arch. Pathol. Lab. Med. 140(4), 345\u2013350. https:\/\/doi.org\/10.5858\/arpa.2015-0519-RA (2016).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"1","key":"66771_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan, M. J. & Liu, Z. G. Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell. Res. 21(1), 103\u2013115. https:\/\/doi.org\/10.1038\/cr.2010.178 (2011).","journal-title":"Cell. Res."},{"issue":"3","key":"66771_CR17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/ijms26031204","volume":"30","author":"ME Kim","year":"2025","unstructured":"Kim, M. E. & Lee, J. S. Advances in the Regulation of Inflammatory Mediators in Nitric Oxide Synthase: Implications for Disease Modulation and Therapeutic Approaches. Int. J. Mol. Sci. 30(3), 1204. https:\/\/doi.org\/10.3390\/ijms26031204 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"66771_CR18","doi-asserted-by":"publisher","first-page":"115147","DOI":"10.1016\/j.bcp.2022.115147","volume":"202","author":"DB Carlos","year":"2022","unstructured":"Carlos, D. B. & Guillermo, E. PXR as the tipping point between innate immune response, microbial infections, and drug metabolism. Biochem. Pharmacol. 202, 115147. https:\/\/doi.org\/10.1016\/j.bcp.2022.115147 (2022).","journal-title":"Biochem. Pharmacol."},{"issue":"26","key":"66771_CR19","doi-asserted-by":"publisher","first-page":"17882","DOI":"10.1074\/jbc.M601302200","volume":"281","author":"X Gu","year":"2006","unstructured":"Gu, X. et al. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J. Biol. Chem. 281(26), 17882\u201317889. https:\/\/doi.org\/10.1074\/jbc.M601302200 (2006).","journal-title":"J. Biol. Chem."},{"key":"66771_CR20","doi-asserted-by":"publisher","first-page":"154097","DOI":"10.1016\/j.phymed.2022.154097","volume":"101","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90\u03b1, and RXR\u03b1. Phytomedicine 101, 154097. https:\/\/doi.org\/10.1016\/j.phymed.2022.154097 (2022).","journal-title":"Phytomedicine"},{"key":"66771_CR21","doi-asserted-by":"publisher","first-page":"107779","DOI":"10.1016\/j.phrs.2025.107779","volume":"216","author":"Y Feng","year":"2025","unstructured":"Feng, Y., Kim, J. W. & Xie, W. The intestinal functions of PXR and CAR. Pharmacol. Res. 216, 107779. https:\/\/doi.org\/10.1016\/j.phrs.2025.107779 (2025).","journal-title":"Pharmacol. Res."},{"issue":"1","key":"66771_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/03602532.2012.746363","volume":"45","author":"S Mani","year":"2013","unstructured":"Mani, S., Dou, W. & Redinbo, M. R. PXR antagonists and implication in drug metabolism. Drug Metab. Rev. 45(1), 60\u201372. https:\/\/doi.org\/10.3109\/03602532.2012.746363 (2013).","journal-title":"Drug Metab. Rev."},{"issue":"11","key":"66771_CR23","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3390\/cells9112395","volume":"9","author":"DC Martine","year":"2020","unstructured":"Martine, D. C. & Sabine, G. C. Regulation of CAR and PXR Expression in Health and Disease. Cells 9(11), 2395. https:\/\/doi.org\/10.3390\/cells9112395 (2020).","journal-title":"Cells"},{"issue":"6","key":"66771_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tips.2012.03.003","volume":"33","author":"J Cheng","year":"2012","unstructured":"Cheng, J., Shah, Y. M. & Gonzalez, F. J. Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol. Sci. 33(6), 323\u2013330. https:\/\/doi.org\/10.1016\/j.tips.2012.03.003 (2012).","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"66771_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jep.2008.03.016","volume":"118","author":"H Lim","year":"2008","unstructured":"Lim, H., Lee, J. G., Lee, S. H., Kim, Y. S. & Kim, H. P. Anti-inflammatory activity of phillygenin, a lignan from the fruits of Forsythia koreana, and its cellular mechanism of action. J. Ethnopharmacol. 118(1), 113\u2013117. (2008). https:\/\/doi.org\/10.1016\/j.jep.2008.03.016","journal-title":"J. Ethnopharmacol."},{"key":"66771_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3389\/fphar.2018.00401","volume":"9","author":"M Barbara","year":"2018","unstructured":"Barbara, M. et al. Lignans From Forsythia x Intermedia Leaves and Flowers Attenuate the Pro-inflammatory Function of Leukocytes and Their Interaction With Endothelial Cells. Front. Pharmacol. 9, 401. https:\/\/doi.org\/10.3389\/fphar.2018.00401 (2018).","journal-title":"Front. Pharmacol."},{"key":"66771_CR27","doi-asserted-by":"publisher","first-page":"115410","DOI":"10.1016\/j.biopha.2023.115410","volume":"166","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives. Biomed. Pharmacother. 166, 115410. https:\/\/doi.org\/10.1016\/j.biopha.2023.115410 (2023).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"66771_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/08923973.2018.1547742","volume":"41","author":"B Du","year":"2019","unstructured":"Du, B. et al. Phillygenin exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes. Immunopharmacol. Immunotoxicol. 41(1), 76\u201385. https:\/\/doi.org\/10.1080\/08923973.2018.1547742 (2019).","journal-title":"Immunopharmacol. Immunotoxicol"},{"issue":"2","key":"66771_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/pharmaceutics12020130","volume":"12","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Self-Microemulsifying Drug Delivery System of Phillygenin: Formulation Development, Characterization and Pharmacokinetic Evaluation. Pharmaceutics 12(2), 130. https:\/\/doi.org\/10.3390\/pharmaceutics12020130 (2020).","journal-title":"Pharmaceutics"},{"issue":"2S","key":"66771_CR30","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jfda.2017.11.007","volume":"26","author":"CH Brett","year":"2018","unstructured":"Brett, C. H., Guan, X., Folan, M. M. & Xie, W. PXR as a mediator of herb-drug interaction. J. Food Drug Anal. 26(2S), S26\u2013S31. https:\/\/doi.org\/10.1016\/j.jfda.2017.11.007 (2018).","journal-title":"J. Food Drug Anal."},{"issue":"1","key":"66771_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jep.2011.04.022","volume":"136","author":"C Yu","year":"2011","unstructured":"Yu, C., Chai, X., Yu, L., Chen, S. & Zeng, S. Identification of novel pregnane X receptor activators from traditional Chinese medicines. J. Ethnopharmacol. 136(1), 137\u2013143. https:\/\/doi.org\/10.1016\/j.jep.2011.04.022 (2011).","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"66771_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1051\/medsci\/2008243301","volume":"24","author":"JM Pascussi","year":"2008","unstructured":"Pascussi, J. M. & Vilarem, M. J. Inflammation and drug metabolism: NF-kappB and the CAR and PXR xeno-receptors. Med. Sci. (Paris). 24(3), 301\u2013305. https:\/\/doi.org\/10.1051\/medsci\/2008243301 (2008).","journal-title":"Med. Sci. (Paris)"},{"issue":"11","key":"66771_CR33","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.3390\/cells10113137","volume":"10","author":"JP Rigalli","year":"2021","unstructured":"Rigalli, J. P., Theile, D., Nilles, J. & Weiss, J. Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning. Cells 10(11), 3137. https:\/\/doi.org\/10.3390\/cells10113137 (2021).","journal-title":"Cells"},{"issue":"14","key":"66771_CR34","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1016\/j.jmb.2013.04.012","volume":"425","author":"BD Wallace","year":"2013","unstructured":"Wallace, B. D. et al. Structural and functional analysis of the human nuclear xenobiotic receptor PXR in complex with RXR\u03b1. J. Mol. Biol. 425(14), 2561\u20132577. https:\/\/doi.org\/10.1016\/j.jmb.2013.04.012 (2013).","journal-title":"J. Mol. Biol."},{"issue":"5","key":"66771_CR35","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"R Brigelius-Floh\u00e9","year":"2013","unstructured":"Brigelius-Floh\u00e9, R. & Maiorino, M. Glutathione peroxidases. Biochim. Biophys. Acta. 1830(5), 3289\u20133303. https:\/\/doi.org\/10.1016\/j.bbagen.2012.11.020 (2013).","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"66771_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/antiox11030501","volume":"11","author":"J Fujii","year":"2022","unstructured":"Fujii, J., Homma, T. & Osaki, T. Superoxide Radicals in the Execution of Cell Death. Antioxid. (Basel). 11(3), 501. https:\/\/doi.org\/10.3390\/antiox11030501 (2022).","journal-title":"Antioxid. (Basel)"},{"key":"66771_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.redox.2015.10.006","volume":"6","author":"FA Moura","year":"2015","unstructured":"Moura, F. A., Andrade, K. Q., Santos, J. C., Ara\u00fajo, O. R. & Goulart, M. O. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol. 6, 617\u2013639. https:\/\/doi.org\/10.1016\/j.redox.2015.10.006 (2015).","journal-title":"Redox Biol."},{"issue":"2","key":"66771_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cellimm.2011.09.014","volume":"272","author":"KS Kumar","year":"2012","unstructured":"Kumar, K. S. et al. Anti-inflammatory potential of an ethyl acetate fraction isolated from Justicia gendarussa roots through inhibition of iNOS and COX-2 expression via NF-\u03baB pathway. Cell. Immunol. 272(2), 283\u2013289. https:\/\/doi.org\/10.1016\/j.cellimm.2011.09.014 (2012).","journal-title":"Cell. Immunol."},{"key":"66771_CR39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s12885-015-1808-6","volume":"15","author":"PS Simon","year":"2015","unstructured":"Simon, P. S. et al. The NF-\u03baB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription. BMC Cancer. 15, 770. https:\/\/doi.org\/10.1186\/s12885-015-1808-6 (2015).","journal-title":"BMC Cancer"},{"issue":"2","key":"66771_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.apsb.2019.06.012","volume":"10","author":"Y Xing","year":"2020","unstructured":"Xing, Y., Yan, J. & Niu, Y. PXR: a center of transcriptional regulation in cancer. Acta Pharm. Sin B. 10(2), 197\u2013206. https:\/\/doi.org\/10.1016\/j.apsb.2019.06.012 (2020).","journal-title":"Acta Pharm. Sin B"},{"issue":"8","key":"66771_CR41","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1172\/JCI26283","volume":"116","author":"C Zhou","year":"2006","unstructured":"Zhou, C. et al. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J. Clin. Invest. 116(8), 2280\u20132289. https:\/\/doi.org\/10.1172\/JCI26283 (2006).","journal-title":"J. Clin. Invest."},{"key":"66771_CR42","doi-asserted-by":"publisher","first-page":"969399","DOI":"10.3389\/fimmu.2022.969399","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun, L., Sun, Z., Wang, Q., Zhang, Y. & Jia, Z. Role of nuclear receptor PXR in immune cells and inflammatory diseases. Front. Immunol. 13, 969399. https:\/\/doi.org\/10.3389\/fimmu.2022.969399 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"66771_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"RM Evans","year":"2014","unstructured":"Evans, R. M., Mangelsdorf, D. J. & Nuclear Receptors RXR, and the Big Bang. Cell 157(1), 255\u2013266. https:\/\/doi.org\/10.1016\/j.cell.2014.03.012 (2014).","journal-title":"Cell"},{"key":"66771_CR44","doi-asserted-by":"publisher","first-page":"1464655","DOI":"10.3389\/fphar.2024.1464655","volume":"15","author":"R Xu","year":"2024","unstructured":"Xu, R., Zhang, L., Pan, H. & Zhang, Y. Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential. Front. Pharmacol. 15, 1464655. https:\/\/doi.org\/10.3389\/fphar.2024.1464655 (2024).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"66771_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1248\/bpb.b24-00037","volume":"48","author":"K Tomita","year":"2025","unstructured":"Tomita, K., Nakashima, K. I., Yamaguchi, E., Itoh, A. & Inoue, M. Dual Anti-inflammatory Actions of a Novel Retinoid X Receptor Agonist Derived from a Natural Compound in Microglial Cells. Biol. Pharm. Bull. 48(4), 440\u2013449. https:\/\/doi.org\/10.1248\/bpb.b24-00037 (2025).","journal-title":"Biol. Pharm. Bull."},{"key":"66771_CR46","doi-asserted-by":"publisher","first-page":"1603287","DOI":"10.3389\/fphar.2025.1603287","volume":"16","author":"F Wang","year":"2025","unstructured":"Wang, F. et al. Oxidative stress in ARDS: mechanisms and therapeutic potential. Front. Pharmacol. 16, 1603287. https:\/\/doi.org\/10.3389\/fphar.2025.1603287 (2025).","journal-title":"Front. Pharmacol."},{"key":"66771_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fphys.2020.00036","volume":"11","author":"H Domscheit","year":"2020","unstructured":"Domscheit, H., Hegeman, M. A., Carvalho, N. & Spieth, P. M. Molecular dynamics of lipopolysaccharide-induced lung injury in rodents. Front. Physiol. 11, 36. https:\/\/doi.org\/10.3389\/fphys.2020.00036 (2020).","journal-title":"Front. Physiol."},{"issue":"1","key":"66771_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12931-020-01337-9","volume":"21","author":"A Carla","year":"2020","unstructured":"Carla, A. et al. Acute respiratory distress syndrome subphenotypes and therapy responsive traits among preclinical models: protocol for a systematic review and meta-analysis. Respir Res. 21(1), 81. (2020). https:\/\/doi.org\/10.1186\/s12931-020-01337-9","journal-title":"Respir Res."},{"issue":"12","key":"66771_CR49","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1007\/s00134-020-06296-9","volume":"46","author":"MA Matthay","year":"2020","unstructured":"Matthay, M. A. et al. Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Med. 46(12), 2136\u20132152. https:\/\/doi.org\/10.1007\/s00134-020-06296-9 (2020).","journal-title":"Intensive Care Med."},{"issue":"3","key":"66771_CR50","doi-asserted-by":"publisher","first-page":"2452082","DOI":"10.1080\/21688370.2025.2452082","volume":"13","author":"Z Zhu","year":"2025","unstructured":"Zhu, Z., Zhang, Y., Chen, H. & Zhang, H. Cell-cell crosstalk in the pathogenesis of acute lung injury and acute respiratory distress syndrome. Tissue Barriers. 13(3), 2452082. https:\/\/doi.org\/10.1080\/21688370.2025.2452082 (2025).","journal-title":"Tissue Barriers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66771-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:43:58Z","timestamp":1788353038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-66771-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66771"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-66771-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and received approval from the Ethics Committee of Yantai Yuhuangding Hospital (protocol code 2023\u2009\u2212\u2009398, approval date: November 29, 2023). This study did not involve human participants, human data, or human tissue.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27535"}}